Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells.
Cancer Invest. 2009 Feb;27(2):178-83. doi: 10.1080/07357900802570759.
Cancer Invest. 2009.
PMID: 19235590